abstract |
A solid dispersion of N4-(4-([1, 2, 4]triazolo[1,5-a]pyridin-7-yloxy)-3- methylpheny1)-N6-(4,4- dimethy1-4,5-dihydrooxazol-2-y1)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4- (4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3- methylpheny1)-N6-(4,4-dimethy1- 4,5-dihydrooxazol-2- yl)quinazoline-4,6-diamine and uses thereof are provided herein. |